Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Countries for Natural Gas Production (Updated 2024)

Rare Earths Reserves: Top 8 Countries (Updated 2024)

Copper Price Update: Q1 2024 in Review

7 Biggest Lithium-mining Companies

Trending Press Releases

European Lithium to Acquire Leinster Lithium Project in Ireland with CRML Shares

Energy Fuels Announces Agreement for Transformational Acquisition of Base Resources, Creating a Global Leader in Critical Minerals Production with a Focus on Uranium, Rare Earth Elements and Heavy Mineral Sands

SOURCE ROCK ROYALTIES ANNOUNCES 2023 RESULTS INCLUDING RECORD ANNUAL & QUARTERLY FUNDS FROM OPERATIONS

Freegold Announces Start of 2024 Drilling Program at Golden Summit

Galan Signs Pivotal Commercial Agreement with Catamarca Government to Commercialise Lithium Chloride Concentrate

Indicative, Conditional and Non-Binding Proposal Received by American Rare Earths

More Press Releases
Trending Companies

Galan Lithium

GLN:AU

International Graphite

IG6:AU

Heritage Mining

HML:CC

Energy Fuels

UUUU
More Companies
Trending Reports

Lithium Outlook for Australia

2024 Gold Outlook Report

2024 Uranium Outlook (Updated for Q2)

2024 Copper Market Outlook (Australia Ed.)

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Tenax Therapeutics Inc.

NASDAQ:TENX
Press Releases

Tenax Therapeutics Updates on Phase 2 Pulmonary Trial

Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. The Company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding their Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). For more information, visit www.tenaxthera.com.

×